Role for Tas2Rs in opioid addiction
Role for Tas2Rs in opioid addiction
批准号:
10177030
负责人:
Paul J. Kenny
金额:
$16.95万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2021-05-31
关键词:
AffectiveAlkaloidsAttenuatedAwardBehavioralBiological AssayBrainCRISPR/Cas technologyCellsCleaved cellClustered Regularly Interspaced Short Palindromic RepeatsCocaineConsumptionDataDevelopmentDoseFemaleFundingG-Protein-Coupled ReceptorsGTP-Binding ProteinsGenesGenetic TranscriptionGenomeGlutamatesGoalsHabenulaIngestionInjectionsIntakeIntravenousKnock-outManuscriptsMeasuresMediatingModalityMolecularMorphineMotivationMusNatureNeuronsNicotineNicotine DependenceNucleus solitariusOpiate AddictionOpioidOpioid ReceptorOxycodonePharmaceutical PreparationsPlant alkaloidPlantsProceduresPropertyPsychological reinforcementPublishingRattusReceptor SignalingRewardsRoleSelf AdministrationSensorySignal TransductionSiteStructureStructure of choroid plexusSystemTaste BudsTaste PerceptionTherapeuticTissuesWithdrawaladdictionalpha-gustducinbehavioral responsechromatin immunoprecipitationconditioned place preferenceconditioningdrug actiondrug of abuseexperimental studymalemu opioid receptorsnovelopioid use disorderopioid withdrawalreceptorresponsesensorsingle-cell RNA sequencingtranscription factortranscriptome sequencing
中文摘要
项目概要:
阿片类药物如羟考酮被认为作用于成瘾相关的大脑回路
专门通过阿片受体,最著名的是μ阿片受体(MORs)。共同
与其他成瘾性药物一样,吗啡是一种植物衍生的生物碱,
味觉,一种进化来防止摄入潜在的
有毒物质合成和半合成阿片类药物,如羟考酮也有生物碱
结构和苦味。味觉2受体(T2R)进化为检测潜在的有毒物质
生物碱,但它们在阿片类药物成瘾相关行为中的潜在参与是
不知道尼古丁最近,我们确定了T2受体在调节厌恶性
尼古丁的行为动作,促使尼古丁避免和防止成瘾。
在这里,我们将探讨T2R在调节阿片类药物的回避中的作用。T2Rs信号通过
称为α-gustducin的专门G蛋白,其来源于Gnat3基因。实验
1,我们将评估羟考酮在野生型和Gnat 3-/-
小鼠使用条件性位置偏爱和回避条件。在实验2中,我们将
评估羟考酮在野生型和Gnat 3-/-小鼠中的强化特性,
静脉内自我给药程序。在实验3中,我们将评估物理和
羟考酮依赖性野生型和Gnat3-/-小鼠中阿片类戒断的情感成分。
在实验4中,我们将确定T2Rs的哪些亚型"cmehosense"羟考酮和其他亚型。
阿片类药物这些实验有可能建立一个全新的类
这些受体可以被靶向用于开发新的成瘾治疗剂。
英文摘要
Project Summary:
Opioid drugs such as oxycodone are thought to act on addiction-relevant brain circuits
exclusively through opioid receptors, most notably the μ opioid receptors (MORs). In common
with other addictive drugs, morphine is a plant-derived alkaloid with an innately aversive bitter
taste, a sensory modality that evolved to protect against ingestion of potentially
noxious substances. Synthetic and semisynthetic opioids such as oxycodone also have alkaloid
structures and a bitter taste. Taste 2 receptors (T2Rs) evolved to detect potentially poisonous
alkaloids, but their potential involvement in the addiction-related behavioral actions of opioids is
unknown to nicotine. Recently, we established a key role for T2Rs in regulating the aversive
behavioral actions of nicotine that motivate nicotine avoidance and protect against addiction.
Here, we will explore the role for T2Rs in regulating avoidance of opioids. T2Rs signal through a
specialized G protein called α-gustducin, which is derived from the Gnat3 gene. In Experiment
1, we will assess the rewarding and aversive properties of oxycodone in wild-type and Gnat3-/-
mice using conditioned place preference and avoidance conditioning. In Experiment 2, we will
assess the reinforcing properties of oxycodone in wild-type and Gnat3-/- mice using the
intravenous self-administration procedure. In Experiment 3, we will assess physical and
affective components of opioid withdrawal in oxycodone-dependent wild-type and Gnat3-/- mice.
In Experiment 4, we will determine which subtypes of T2Rs `cmehosense' oxycodone and other
opioid drugs. These experiments have the potential to establish an entirely new class of
receptors that can be targeted for the development of novel addiction therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Single cell transcriptomic and epigenomic changes during chronic HIV infection and cocaine self-administration
-
批准号:10629335
-
项目类别:
-
资助金额:$364.85万
-
财政年份:2022
-
负责人:Paul J. Kenny
-
依托单位:
Single cell transcriptomic and epigenomic changes during chronic HIV infection and cocaine self-administration
-
批准号:10454708
-
项目类别:
-
资助金额:$355.77万
-
财政年份:2022
-
负责人:Paul J. Kenny
-
依托单位:
Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice
-
批准号:10405624
-
项目类别:
-
资助金额:$264.12万
-
财政年份:2021
-
负责人:Paul J. Kenny
-
依托单位:
Training Program in Substance Use Disorders
-
批准号:10623170
-
项目类别:
-
资助金额:$55.32万
-
财政年份:2021
-
负责人:Paul J. Kenny
-
依托单位:
Training Program in Substance Use Disorders
-
批准号:10206956
-
项目类别:
-
资助金额:$12.46万
-
财政年份:2021
-
负责人:Paul J. Kenny
-
依托单位:
Training Program in Substance Use Disorders
-
批准号:10383775
-
项目类别:
-
资助金额:$39.94万
-
财政年份:2021
-
负责人:Paul J. Kenny
-
依托单位:
Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice
-
批准号:10594562
-
项目类别:
-
资助金额:$250.66万
-
财政年份:2021
-
负责人:Paul J. Kenny
-
依托单位:
Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice
-
批准号:10220584
-
项目类别:
-
资助金额:$265.47万
-
财政年份:2021
-
负责人:Paul J. Kenny
-
依托单位:
Role for Circular RNAs in Compulsive Cocaine Intake
-
批准号:10533296
-
项目类别:
-
资助金额:$26.7万
-
财政年份:2019
-
负责人:Paul J. Kenny
-
依托单位:
Role for Circular RNAs in Compulsive Cocaine Intake
-
批准号:10306369
-
项目类别:
-
资助金额:$26.7万
-
财政年份:2019
-
负责人:Paul J. Kenny
-
依托单位:
Role for Circular RNAs in Compulsive Cocaine Intake
-
批准号:10062505
-
项目类别:
-
资助金额:$24.09万
-
财政年份:2019
-
负责人:Paul J. Kenny
-
依托单位:
Habenular immune signaling and addiction
-
批准号:10197076
-
项目类别:
-
资助金额:$58.87万
-
财政年份:2018
-
负责人:Paul J. Kenny
-
依托单位:
Habenular immune signaling and addiction
-
批准号:9789860
-
项目类别:
-
资助金额:$58.87万
-
财政年份:2018
-
负责人:Paul J. Kenny
-
依托单位:
Habenular immune signaling and addiction
-
批准号:10437801
-
项目类别:
-
资助金额:$58.87万
-
财政年份:2018
-
负责人:Paul J. Kenny
-
依托单位:
MicroRNAs in schizophrenia
-
批准号:9918450
-
项目类别:
-
资助金额:$42.12万
-
财政年份:2017
-
负责人:Paul J. Kenny
-
依托单位:
MicroRNAs in schizophrenia
-
批准号:10166931
-
项目类别:
-
资助金额:$42.12万
-
财政年份:2017
-
负责人:Paul J. Kenny
-
依托单位:
Nicotinic receptors and alcohol reinforcement
-
批准号:9905468
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2016
-
负责人:Paul J. Kenny
-
依托单位:
Nicotinic receptors and alcohol reinforcement
-
批准号:9176577
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2016
-
负责人:Paul J. Kenny
-
依托单位:
Orexin receptor antagonists for drug addiction and panic disorder
-
批准号:8830802
-
项目类别:
-
资助金额:$9.16万
-
财政年份:2014
-
负责人:Paul J. Kenny
-
依托单位:
Orexin receptor antagonists for drug addiction and panic disorder
-
批准号:8856678
-
项目类别:
-
资助金额:$9.16万
-
财政年份:2014
-
负责人:Paul J. Kenny
-
依托单位:
国内基金
海外基金
Iboga alkaloids骨架导向的不对称串联反应构建吖庚环并[4,5-b]吲哚及其在全合成中的应用
-
批准号:21801032
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2018
-
负责人:陈惠渝
-
依托单位: